Led by Robert Bone, PhD, assistant professor at the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), the ...

We also talk about today’s DNA-related advances that use machine learning to design tailored Cas9 proteins, and multiple sequencing technologies to study mutation rates in four generations of the same ...

AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...

Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...